Table 1 Patients characteristics at baseline
Fluid responders | Fluid nonresponders | P | |
|---|---|---|---|
n = 15 | n = 15 | ||
Age, years | 62 ± 10 | 67 ± 13 | 0.25 |
Weight, kg | 78 ± 22 | 78 ± 22 | 0.99 |
Height, cm | 169 ± 10 | 168 ± 13 | 0.76 |
Shock aetiology | |||
Septic (n, %) | 9 (60 %) | 10 (67 %) | 1,00 |
Cardiogenic (n, %) | 4 (27 %) | 4 (27 %) | 1,00 |
Hypovolemic (n,%) | 2 (13 %) | 1 (6 %) | 1,00 |
Simplified Acute Physiologic Score II | 56 ± 20 | 60 ± 14 | 0.45 |
Male gender (n, %) | 9 (60 %) | 12 (80 %) | 0.43 |
Tidal volume, mL/kg of ideal body weight | 6.5 ± 1,0 | 6.6 ± 1,0 | 0.67 |
Patients receiving norepinephrine (n, %) | 14 (94 %) | 9 (60 %) | 0.08 |
Dose of norepinephrine, ig/kg/min | 0.40 ± 0,32 | 0.28 ± 0.34 | 0.31 |
Patients receiving dobutamine (n,%) | 1 (6 %) | 2 (13 %) | 1,00 |
Dose of dobutamine, g/kg/min | 0.67 ± 2.58 | 0.67 ± 1.76 | 1,00 |
Renal replacement therapy (n, %) | 6 (40 %) | 6 (40 %) | 1,00 |
Patients receiving propofol (n,%) | 14 (94 %) | 15 (100 %) | 1,00 |
Dose of propofol, mg/h | 183 ± 99 | 207 ± 68 | 0.46 |
Patients receiving rem ifentanyl (n, %) | 7 (47 %) | 8 (53 %) | 1 |
Dose ofremifentanyl, μg/h | 113 ± 146 | 97 ± 130 | 0.74 |